210 related articles for article (PubMed ID: 38881904)
1. Tumor glucose metabolism and the T cell glycocalyx: implication for T cell function.
Schuurmans F; Wagemans KE; Adema GJ; Cornelissen LAM
Front Immunol; 2024; 15():1409238. PubMed ID: 38881904
[TBL] [Abstract][Full Text] [Related]
2. Immunological Aspects of Cancer Cell Metabolism.
Ucche S; Hayakawa Y
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791327
[TBL] [Abstract][Full Text] [Related]
3. The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy.
Lim AR; Rathmell WK; Rathmell JC
Elife; 2020 May; 9():. PubMed ID: 32367803
[TBL] [Abstract][Full Text] [Related]
4. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
Balta E; Wabnitz GH; Samstag Y
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
[TBL] [Abstract][Full Text] [Related]
5. Dysfunctional T cell metabolism in the tumor microenvironment.
Beckermann KE; Dudzinski SO; Rathmell JC
Cytokine Growth Factor Rev; 2017 Jun; 35():7-14. PubMed ID: 28456467
[TBL] [Abstract][Full Text] [Related]
6. The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.
Petitprez F; Meylan M; de Reyniès A; Sautès-Fridman C; Fridman WH
Front Immunol; 2020; 11():784. PubMed ID: 32457745
[TBL] [Abstract][Full Text] [Related]
7. NK Cell Metabolism and Tumor Microenvironment.
Terrén I; Orrantia A; Vitallé J; Zenarruzabeitia O; Borrego F
Front Immunol; 2019; 10():2278. PubMed ID: 31616440
[TBL] [Abstract][Full Text] [Related]
8. Mechanoimmunology in the solid tumor microenvironment.
Golo M; Newman PLH; Kempe D; Biro M
Biochem Soc Trans; 2024 Jun; 52(3):1489-1502. PubMed ID: 38856041
[TBL] [Abstract][Full Text] [Related]
9. Immunometabolism: A new target for improving cancer immunotherapy.
Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
[TBL] [Abstract][Full Text] [Related]
10. Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity.
Zhang S; Zhang X; Yang H; Liang T; Bai X
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189022. PubMed ID: 37993001
[TBL] [Abstract][Full Text] [Related]
11. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
Nachef M; Ali AK; Almutairi SM; Lee SH
Front Immunol; 2021; 12():624324. PubMed ID: 33953707
[TBL] [Abstract][Full Text] [Related]
12. Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy.
Kouidhi S; Ben Ayed F; Benammar Elgaaied A
Front Immunol; 2018; 9():353. PubMed ID: 29527212
[TBL] [Abstract][Full Text] [Related]
13. Glycosylation Targeting: A Paradigm Shift in Cancer Immunotherapy.
Ren X; Lin S; Guan F; Kang H
Int J Biol Sci; 2024; 20(7):2607-2621. PubMed ID: 38725856
[TBL] [Abstract][Full Text] [Related]
14. Allies or Enemies-The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment.
Haas L; Obenauf AC
Front Immunol; 2019; 10():2746. PubMed ID: 31849950
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Factors Affecting Tumor Immunogenicity: What Is Happening at the Cellular Level?
El Sayed R; Haibe Y; Amhaz G; Bouferraa Y; Shamseddine A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670011
[TBL] [Abstract][Full Text] [Related]
16. The essential link: How STAT3 connects tumor metabolism to immunity.
Zhong S; Tong J
Biochim Biophys Acta Gene Regul Mech; 2024 Jun; 1867(2):195028. PubMed ID: 38636823
[TBL] [Abstract][Full Text] [Related]
17. Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies.
Anderson KG; Stromnes IM; Greenberg PD
Cancer Cell; 2017 Mar; 31(3):311-325. PubMed ID: 28292435
[TBL] [Abstract][Full Text] [Related]
18. Lipids for CD8
Wu D; Chen Y
Front Immunol; 2022; 13():1020422. PubMed ID: 36275711
[TBL] [Abstract][Full Text] [Related]
19. Combining precision oncology and immunotherapy by targeting the MALT1 protease.
Mempel TR; Krappmann D
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36270731
[TBL] [Abstract][Full Text] [Related]
20. Expression of costimulatory and inhibitory receptors in FoxP3
Toker A; Ohashi PS
Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
